filmov
tv
Featured Fireside Chat: FDA Perspective
Показать описание
Chair:
Janet Lambert, CEO, Alliance for Regenerative Medicine (ARM)
Speaker:
Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration (FDA)
Janet Lambert, CEO, Alliance for Regenerative Medicine (ARM)
Speaker:
Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration (FDA)
1:10:39
Featured Fireside Chat: FDA Perspective
0:38:22
Fireside Chat: FDA Perspective
0:51:31
Fireside Chat on Impact on Rare Diseases at FDA
0:18:08
The Future Use of Complex Biomarkers: Fireside Chat
0:10:22
3/21/2016 - FDA Perspective
1:00:18
Fireside Chat: A Peek Inside the FDA Process and Advice from Successful Healthtech Entrepreneurs
0:15:00
Dr. Richard Pazdur and Ellen Sigal Fireside Chat
0:31:20
2017 WMIF | 1:1 Fireside Chat: Robert Califf, MD, Commissioner (former), FDA
0:00:42
Preview: CBER Director Peter Marks Discusses FDA's Credibility at ARM's 2020 Meeting on th...
0:38:12
Keynote Speech and Fireside Chat: Brave New World: Adapting to Change
0:17:52
Young & Partners Pharmaceutical Executive Summit: Peter Marks Fireside Chat
1:15:22
15th Annual Sentinel Workshop Keynote and Fireside Chat with Sentinel Initiative Leadership
0:00:40
Preview: CBER Director Peter Marks on 'Onslaught' of Gene Therapy Applications at FDA
0:03:24
The FDA and Vaccines
0:37:04
RMAT Policy Briefing with FDA Commissioner
0:13:59
FDA's Programs to Promote Patient Access to Investigational Therapies
2:59:01
2023 TOP FDA Diagnostic Data Solutions Showcase
0:57:04
The Future Use of Complex Biomarkers
0:20:23
FDA’s Efforts to Facilitate the Development of Safe & Effective Regenerative Medicine Products
0:42:00
Resident Selection - A Program's Perspective [FireSide Chat with Saira Kalia - Associate PD Psy...
0:00:52
Director of FDA's CBER, Peter Marks, M.D., Ph.D. on COVID-19 Vaccine Confidence
0:28:17
Featured Fireside Chat: Brexit's Effect on Cell and Gene Therapy Regulation
1:16:46
Friends of Cancer Research Annual Meeting Day 2
0:31:22
The Impacts of FDA Regulations on Diagnostics in Oncology
Комментарии